Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:developedBy |
STX107
STX209 (arbaclofen) |
| gptkbp:focusesOn |
gptkb:fragile_X_syndrome
autism spectrum disorders development of drugs for neurodevelopmental disorders |
| gptkbp:foundedBy |
Dr. Randall Carpenter
|
| gptkbp:foundedIn |
2005
|
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Seaside Therapeutics
|
| gptkbp:notableEmployee |
Dr. Randall Carpenter
|
| gptkbp:status |
defunct
|
| gptkbp:bfsParent |
gptkb:STX-101
|
| gptkbp:bfsLayer |
8
|